宁波美诺华药业股份有限公司2025年第三季度报告

Core Viewpoint - The company, Ningbo Meinuo Pharmaceutical Co., Ltd., has released its third-quarter report for 2025, ensuring the accuracy and completeness of the information provided [2][8]. Financial Data - The third-quarter financial statements have not been audited [3]. - The report includes major accounting data and financial indicators, with specific emphasis on non-recurring gains and losses [4][5]. Board Meeting - The company's 18th meeting of the 5th Board of Directors was held on October 27, 2025, with all five directors present, complying with relevant laws and regulations [9]. - The meeting approved the 2025 third-quarter report, which was reviewed by the audit committee prior to submission [10][11]. Voting Results - The resolution to approve the third-quarter report received unanimous support, with all five votes in favor and no opposition or abstentions [12][13].